Welcome to our dedicated page for AXT SEC filings (Ticker: AXTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AXT, Inc. filings document the regulatory disclosures of a Nasdaq-listed manufacturer of compound semiconductor substrate wafers. Recent Form 8-K reports cover results of operations and financial condition, Regulation FD information, exhibit filings for earnings releases, and capital-structure disclosures involving its common stock.
The filing record also includes material definitive agreement disclosure for an underwriting agreement, exchange-registration information for AXTI common stock, and definitive proxy materials addressing shareholder voting matters, board and committee governance, director independence, and executive compensation.
AXT Inc. (AXTI) CEO stock sale reported
The CEO of AXT Inc. reported selling 33,130 shares of the company’s common stock on 11/17/2025. The sale is coded as transaction type “S,” which indicates an open-market or private sale transaction. The weighted average sale price was $10.395 per share, with individual trades executed between $10.15 and $10.81 per share.
After this transaction, the reporting person beneficially owns 2,476,360 shares of AXT common stock in direct ownership form. The filer notes that detailed trade information for each price level is available upon request by regulators, the company, or its shareholders.
AXT Inc. (AXTI) CEO stock transaction: The company’s chief executive officer reported exercising stock options for 70,000 shares of common stock on 11/14/2025 at an exercise price of $5.21 per share. These options were originally granted on 10/28/2016 and first became exercisable on 10/28/2017. Following this transaction, the CEO directly beneficially owns 2,509,490 shares of AXT common stock and holds 621,953 stock options for common shares.
AXT Inc (AXTI) disclosed an insider transaction on a Form 4: the CFO sold 101,297 shares of common stock on 11/13/2025 at a weighted average price of $10.138, with individual trades between $10.05 and $10.28. After these sales, the reporting person beneficially owned 361,997 shares, held directly. The filing states full trade-by-trade details are available upon request.
AXT, Inc. reported Q3 2025 results showing year-over-year improvement in the quarter but weaker performance year to date. Revenue was $27.955 million versus $23.645 million a year ago, and gross profit rose to $6.224 million from $5.682 million. The net loss attributable to AXT narrowed to $1.906 million from $2.937 million, or ($0.04) per share compared with ($0.07). For the nine months, revenue was $65.285 million versus $74.256 million, and the net loss widened to $17.712 million.
Cash and cash equivalents were $23.110 million with $8.100 million of restricted cash. Inventories declined to $77.656 million, while accounts receivable increased to $33.837 million. Short‑term loans rose to $61.547 million. Total assets were $334.034 million, and total stockholders’ equity was $202.345 million. AXT remains the controlling stakeholder of Tongmei; noncontrolling and redeemable noncontrolling interests together were approximately 14.5% as of September 30, 2025. The company’s investment in Jia Mei was $702,000 after a fair value loss and subsequent gain recognized during Q2–Q3.
AXT Inc. (AXTI) reported an insider transaction on Form 4. A director sold 3,637 shares of common stock on 11/07/2025 at $8.41 per share.
Following the sale, the reporting person directly owns 118,875 shares. The filing was signed by attorney-in-fact Jeff Sensiba on 11/10/2025.
AXT, Inc. filed an S-3 shelf registration to offer up to $100,000,000 of securities from time to time after effectiveness. The mixed shelf may include common stock, preferred stock, debt securities, depositary shares, warrants, subscription rights, purchase contracts and units, with specific terms to be set in future supplements.
AXT’s common stock trades on the Nasdaq Global Select Market under the symbol AXTI. AXT states it believes no PRC central government permissions are required to complete this offering, while noting its manufacturing is conducted by PRC subsidiaries and joint ventures and highlighting related legal and operational risks. Unless otherwise specified in a supplement, net proceeds will be used for working capital and general corporate purposes. Securities may be sold directly or via agents, underwriters or dealers, with pricing determined at the time of each offering. The company does not anticipate paying cash dividends and qualifies as a smaller reporting company.
AXT Inc. (AXTI) reported an insider transaction by a director. On 11/05/2025, the director executed an open-market sale (code S) of 100,000 shares of common stock at $8.9404 per share. Following the sale, the director directly beneficially owns 207,744 shares. The filing indicates the form was submitted by one reporting person.
AXT Inc (AXTI) reported an insider transaction by its CFO. On 11/06/2025, the officer sold 22,675 shares of common stock in an open‑market transaction at a weighted average price of $8.8722.
The filing notes the sales occurred across multiple trades within a price range of $8.85 to $8.96. Following the transaction, the officer beneficially owned 463,294 shares, held directly.
AXT Inc. (AXTI) disclosed insider stock sales by its CFO. On 11/04/2025, the officer sold 27,720 shares of common stock at a weighted average price of $8.0874, leaving 538,484 shares beneficially owned directly. On 11/05/2025, a further 52,515 shares were sold at a weighted average price of $9.2088, resulting in 485,969 shares beneficially owned directly after the transactions. The sales were executed through multiple trades within stated price ranges.
AXT, Inc. (AXTI) reported insider activity by its CEO on Form 4. On 10/31/2025, the reporting person made a gift of 30,000 common shares at $0. Following this gift, 2,519,490 shares were beneficially owned directly.
On 11/03/2025, the reporting person sold 80,000 common shares at a weighted average price of $8.6481, with individual trades ranging from $8.38 to $9.16. Following this sale, 2,439,490 shares were beneficially owned indirectly by the Young Family Trust.